News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
3 stories
Tagged Neurology from the headline and teaser, so some stories may be missed or misfiled.
- RecallFDA enforcement reportsAug 11, 2026Class I recall: American Regent, Inc. - Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous...
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
- RecallFDA enforcement reportsJul 31, 2026Class I recall: Liebel-Flarsheim Company LLC - Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL...
Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.
- RecallFDA enforcement reportsJul 24, 2026Class I recall: American Regent, Inc. - Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01),...
Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.